XML 24 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Income (loss) before income taxes from continuing operations $ 159,997 $ 23,870 $ (43,106)
Loss before income taxes from discontinued operations 0 0 (1,053)
Adjustments to reconcile income (loss) before income taxes to net cash flows:      
Share-based payment expense 14,926 9,073 9,785
Adjustments for depreciation and amortisation expense 13,165 13,939 19,600
Impairment of non-financial assets 681 3,194 5,624
Share of net loss of equity-accounted investees 0 6 29,376
Impairment of equity-accounted investee 0 0 115,477
Fair value gain on investments (89,838) (1,500) (116,561)
Net finance expense (income) (7,269) 18,224 8,603
Other adjustments (255) (452) (1,833)
Changes in working capital:      
Change in trade and other receivables (17,956) (19,299) (7,291)
Change in prepayments (500) 4,253 (132)
Change in trade and other payables 5,310 8,559 12,925
Change in deferred revenue 9,277 (97) 747
Change in other liabilities 1,158 3 (146)
Income taxes paid (5,937) (3,111) (5,452)
Net cash flow from operating activities 82,761 56,662 26,564
Cash flows from investing activities:      
Purchase of equipment (1,873) (3,187) (1,060)
Purchase of intangible assets (250) 0 0
Development expenditure (4,281) (6,789) (4,836)
Acquisition of subsidiary, net of cash acquired 0 0 (9,008)
Proceeds from sale of shares in associate 0 36,879 50,000
Net sale (purchase) of listed equity instruments 23,414 16,178 (84,835)
Interest income received 2,989 1,368 35
Net cash flow from (used in) investing activities 19,999 44,450 (49,703)
Cash flows from financing activities:      
Acquisition of treasury shares (32,695) (146,068) (749)
Proceeds from exercise of share options 394 0 0
Dividends paid (23,105) 0 0
Interests on loans and borrowings (369) (293) (316)
Repayment of loans and borrowings (161) (378) (499)
Payment of lease liabilities (3,907) (3,837) (5,119)
Net cash flow used in financing activities (59,843) (150,578) (6,683)
Net change in cash and cash equivalents 42,918 (49,465) (29,822)
Cash and cash equivalents at beginning of period 52,414 102,876 134,168
Effect of exchange rate changes on cash and cash equivalents (1,469) (996) (1,472)
Cash and cash equivalents at end of period $ 93,863 $ 52,414 $ 102,876